Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Pharmaceutics|October 23, 2021
Integration of Transcriptomics and Metabolomics to Reveal the Molecular Mechanisms Underlying Rhodium Nanoparticles-Based Photodynamic Cancer TherapyAndres Machuca, Estefania Garcia-Calvo, Daniela S Anunciação, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|April 16, 2020
Rhodium Nanoparticles as a Novel Photosensitizing Agent in Photodynamic Therapy against CancerAndres Machuca, Estefania Garcia-Calvo, Daniela S Anunciação, et al.Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 9, 2020
Integration of untargeted and targeted mass spectrometry-based metabolomics provides novel insights into the potential toxicity associated to surfynolEstefania Garcia-Calvo, Andres Machuca, Cristina Nerín, et al.Advances in Experimental Medicine and Biology|July 27, 2019
Strategies for Membrane Protein Analysis by Mass SpectrometryRafael C Prados-Rosales, Guillermo Aragoneses-Cazorla, Hector Estevez, et al.Methods in Molecular Biology (Clifton, N.J.)|November 12, 2022
Super-SILAC Quantitative Proteome Profiling of Zebrafish LarvaeGuillermo Aragoneses-Cazorla, Andres Machuca, M Pilar Buendia-Nacarino, et al.Journal of Materials Chemistry. B|October 25, 2024
Advancing rhodium nanoparticle-based photodynamic cancer therapy: quantitative proteomics and <i>in vivo</i> assessment reveal mechanisms targeting tumor metabolism, progression and drug resistanceAndres Machuca, Gabriel A Peñalver, Roberto Alvarez-Fernandez Garcia, et al.Journal of Colloid and Interface Science|February 25, 2026
A third-generation rhodium-based nanophotosensitizer for precision photodynamic cancer therapyAndres Machuca, Roberto Alvarez-Fernandez Garcia, Alejandro Garcia-Garcia, et al.Pageof 1